Alithea Biotechnology GmbH
About
Alithea Bio is a biotech company advancing precision immunotherapy through AI-enabled immunopeptidomics and innovative peptide discovery technologies. The company develops next-generation solutions for personalized medicine, focusing on the identification and characterization of clinically relevant peptides to support targeted immunotherapies, biomarker discovery, and translational research.
By combining biotechnology, data science, and scalable laboratory innovation, Alithea Bio aims to accelerate the development of more precise and effective therapeutic approaches for cancer and other immune-related diseases. The company is actively building collaborations with pharmaceutical companies, research institutions, and strategic partners across the global biotech ecosystem.
Representatives
Founder and CEO
Alithea Biotechnology GmbH